Hypoglycaemics Flashcards
Metformin:
Undergoes liver metabolism
False. Metformin is not metabolised and is excreted unchanged in the urine. It is undetectable in plasma at 24 hours after a single dose.
Metformin:
Is effective in overweight diabetics
True. It does not cause weight loss but decreases weight gain in combination with lifestyle modifications.
Metformin:
Overdose can lead to lactic acidosis
True
Metformin:
Has a half life of 6 hours
True. Peak concentrations are reached within one to three hours, but it’s duration of action is between 8 & 12 hours, and is therefore administered up to 3 times a day.
Metformin:
Causes ketonuria
True
Biguanides:
Stimulate pancreatic insulin secretion
False. Biguanide action involves decreased gluconeogenesis, increased glycolysis & decreased intestinal glucose reabsorption.
Biguanides:
Are teratogenic
False. They are not recommended in pregnancy, though are not teratogenic.
Biguanides:
Are used in all ages of diabetics
False. Ketonuria can occur in young diabetics treated with Insulin & Biguanides, and so Metformin is usually only used in adult onset diabetes.
Biguanides:
Metformin has an oral bioavailability of 50-60%
True
Biguanides:
Metformin is highly protein bound
False. Metformin has negligible protein binding.
Sulphonylureas:
Are used in adult onset diabetes
True
Sulphonylureas:
Can cause hypoglycaemia
True. Sulphonylureas, such as Gliclazide, unlike Metformin, can cause hypoglycaemic episodes and blood sugars must be checked regularly.
Sulphonylureas:
Cause lactic acidosis in toxicity
False. Unlike Metformin, they do not cause lactic acidosis.
Sulphonylureas:
Act by increasing insulin release
True. They also enhance Insulin’s effect of taking up glucose into muscle & fat. Other examples include glibenclamide, tolbutamide &, the older preparation, chlopropramide.
Sulphonylureas:
Act by increasing insulin production
False. They act by increasing insulin release (not production) from the pancreatic beta cells, by binding to specific receptors.
Sulphonylurea hypoglycaemics:
Tend to cause weight loss
False
They act by binding to a receptor coupled to increased Calcium entry into the pancreatic beta cells, which enhances Insulin secretion.
Sulphonylurea hypoglycaemics:
Can be used to treat ketoacidosis
False. Oral hypoglycaemics have no role in the management of acute diabetic ketoacidosis.
Sulphonylurea hypoglycaemics:
Are safe for use in pregnancy
False
Sulphonylurea hypoglycaemics:
Are potentiated by Sulphonamides
True
Sulphonylurea hypoglycaemics:
Have shorter half lives than Biguanides
False